NasdaqGM - Nasdaq Real Time Price USD

Alimera Sciences, Inc. (ALIM)

3.6300 0.0000 (0.00%)
As of April 24 at 4:00 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
80,754.0000
80,754.0000
54,129.0000
59,029.0000
50,820.0000
Cost of Revenue
10,837.0000
10,837.0000
7,977.0000
7,030.0000
6,941.0000
Gross Profit
69,917.0000
69,917.0000
46,152.0000
51,999.0000
43,879.0000
Operating Expense
71,849.0000
71,849.0000
57,792.0000
52,200.0000
44,380.0000
Operating Income
-1,932.0000
-1,932.0000
-11,640.0000
-201.0000
-501.0000
Net Non Operating Interest Income Expense
-10,185.0000
-10,185.0000
-5,881.0000
-5,413.0000
-5,380.0000
Other Income Expense
-7,930.0000
-7,930.0000
-558.0000
1,680.0000
474.0000
Pretax Income
-20,047.0000
-20,047.0000
-18,079.0000
-3,934.0000
-5,407.0000
Tax Provision
85.0000
85.0000
28.0000
438.0000
-68.0000
Net Income Common Stockholders
-21,391.0000
-21,391.0000
-18,107.0000
-4,372.0000
-5,339.0000
Diluted NI Available to Com Stockholders
-21,391.0000
-21,391.0000
-18,107.0000
-4,372.0000
-5,339.0000
Basic EPS
-0.84
--
-2.59
-0.66
-1.04
Diluted EPS
-0.84
--
-2.59
-0.66
-1.04
Basic Average Shares
25,561.8850
--
6,996.8500
6,595.2370
5,117.6560
Diluted Average Shares
25,561.8850
--
6,996.8500
6,595.2370
5,117.6560
Total Operating Income as Reported
-1,932.0000
-1,932.0000
-11,640.0000
-201.0000
-501.0000
Total Expenses
82,686.0000
82,686.0000
65,769.0000
59,230.0000
51,321.0000
Net Income from Continuing & Discontinued Operation
-20,132.0000
-20,132.0000
-18,107.0000
-4,372.0000
-5,339.0000
Normalized Income
-13,867.3000
-13,867.3000
-17,666.1800
-5,598.4000
-5,807.3120
Interest Expense
10,185.0000
10,185.0000
5,881.0000
5,413.0000
5,380.0000
Net Interest Income
-10,185.0000
-10,185.0000
-5,881.0000
-5,413.0000
-5,380.0000
EBIT
-9,862.0000
-9,862.0000
-12,198.0000
1,479.0000
-27.0000
EBITDA
-1,115.0000
-1,115.0000
-9,492.0000
4,058.0000
2,649.0000
Reconciled Cost of Revenue
10,837.0000
10,837.0000
7,977.0000
7,030.0000
6,941.0000
Reconciled Depreciation
8,747.0000
8,747.0000
2,706.0000
2,579.0000
2,676.0000
Net Income from Continuing Operation Net Minority Interest
-20,132.0000
-20,132.0000
-18,107.0000
-4,372.0000
-5,339.0000
Total Unusual Items Excluding Goodwill
-7,930.0000
-7,930.0000
-558.0000
1,680.0000
474.0000
Total Unusual Items
-7,930.0000
-7,930.0000
-558.0000
1,680.0000
474.0000
Normalized EBITDA
6,815.0000
6,815.0000
-8,934.0000
2,378.0000
2,175.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0000
Tax Effect of Unusual Items
-1,665.3000
-1,665.3000
-117.1800
453.6000
5.6880
12/31/2020 - 11/4/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ACUR Acura Pharmaceuticals, Inc.
0.0100
0.00%
 
EVOK Evoke Pharma, Inc.
0.4475
0.00%
 
39L.DU PetIQ Inc
15.20
-1.30%
 
MBGPF Moberg Pharma AB (publ)
3.2500
0.00%
 
GRNF GRN Holding Corporation
0.0710
0.00%
 
SBBCF Simply Better Brands Corp.
0.2668
0.00%
 
CLVRW Clever Leaves Holdings Inc.
0.0400
0.00%
 
FITX Creative Edge Nutrition, Inc.
0.0000
0.00%
 
BFRIW Biofrontera Inc.
0.0595
+19.24%
 
CPIX Cumberland Pharmaceuticals Inc.
1.6800
+4.55%